GlassScriptPhysician profile
Emily M Speeg
NPI 1720241177
$1,884.35
in general payments reported to CMS, 2019-2025
18 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $218 · 2021: $512 · 2022: $272 · 2023: $348 · 2024: $80.11 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $977.66 | 2019-2024 | |
| Abbvie INC. | $212.84 | 2019-2021 | |
| Pfizer INC. | $118.14 | 2019-2021 | |
| Lilly USA, LLC | $106.63 | 2025 | Ebglyss |
| Janssen Biotech, INC. | $76.93 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $66.28 | 2020-2021 | |
| Ani Pharmaceuticals, INC. | $45.48 | 2023 | Apexicon E |
| Amgen INC. | $35.24 | 2020-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $34.36 | 2019-2020 | |
| Vyne Pharmaceuticals INC. | $33.73 | 2020 | |
| Leo Pharma INC. | $33.33 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $29.74 | 2019-2020 | |
| Galderma Laboratories, L.P. | $25.68 | 2019 | |
| Incyte Corporation | $21.15 | 2021 | |
| Medimetriks Pharmaceuticals, INC. | $20.43 | 2024 | Clindacin Etz |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $18.51 | 2021 | |
| Ucb, INC. | $16.26 | 2022 | |
| Allergan, INC. | $11.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Speeg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.